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Summary 
Leukocyte extravasation is mediated by multiple interactions of adhesive surface structures with 
ligands on endothelial cells and matrix components. The functional role of 31 (CD29) integrins 
(or very late antigen [VLA] proteins) in eosinophil migration across polycarbonate filters was 
examined under several in vitro conditions. Eosinophil migration induced by the chemoattractant 
C5a or platelet-activating factor was fully inhibited by monoclonal antibody (mAb) 8A2, a recently 
characterized  "activating" CD29 mAb. However,  inhibition by mAb 8A2 was observed only 
under filter conditions that best reflected the in vivo situation, i.e., when the eosinophils migrated 
over filters preincubated with the extracellular matrix (ECM) protein fibronectin (FN), or when 
the filters were covered with confluent monolayers of cultured human umbilical vein endothelial 
cells (HUVEC). When bare untreated filters were used, mAb 8A2 had no effect, whereas the 
C5a-directed movement was prevented by CD18 mAb. Studies with c~-subunit (CD49)-specific 
mAbs indicated that the integrins VLA-4 and -5 mediated migration across FN-preincubated 
falters, and VLA-2, -4, -5, and -6 were involved in eosinophil migration through filters covered 
with HUVEC.  In contrast with the activating CD29 mAb 8A2, a combination of blocking 
CD49 mAbs or the nonactivating but blocking CD29 mAb AIIB2 failed to inhibit completely 
eosinophil migration over FN-preincubated or HUVEC-covered filters, mAb 8A2 stimulated 
binding to FN but not to HUVEC. Moreover,  eosinophil migration over FN-preincubated or 
HUVEC-covered filters was significantly inhibited by anti-connecting segment 1 (CS-1) mAbs, 
as well as the sohble CS-1 peptide (unlike migration across bare untreated falters). Thus, inhibition 
of eosinophil migration by mAb 8A2 depended upon the presence of ECM proteins and not 
upon the presence of HUVEC per se. In conclusion, "freezing" adhesion receptors  of the 31 
integrin family into their high-avidity binding state by the activating CD29 mAb 8A2 results 
in a complete inhibition of eosinophil migration under physiological conditions. Hence, activation 
of 31  integrin-mediated cell  adhesion may represent  a  new approach to  prevent influx of 
inflammatory cells. 
though eosinophils constitute a minor fraction of the 
leukocytes in the circulation, they are a major compo- 
nent of the cellular infiltrate at extravascular sites of inflam- 
mation under certain pathological circumstances,  such as al- 
lergic late phase responses in asthma and atopic skin reactions, 
parasitic infestation, and some delayed-type hypersensitivity 
reactions (1-5). 
At the beginning of this process of localized eosinophilic 
infiltration, the eosinophils leave the vascular compartment. 
The extracellular matrix (ECM) t of the vascular endothelial 
cells comprises all kinds of proteins and heavily glycosylated 
structures (proteoglycans)  to which the infiltrating immune 
cells can attach during this migration along gradients of 
chemotactic factors. Platelet-activating factor (PAF) and the 
1 Abbreviations used in this paper: CS-1,  connecting  segment  1;  ECM, 
extracelhlar matrix; FN, fibronectin;  HUVEC,  human umbilical vein 
endothelial call; PAF, platelet-activating factor; VLA, very late antigen. 
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tractants for eosinophils (6,  7). 
Of the integrin family of adhesion molecules,  the ~/2 sub- 
family of CD11/CD18 molecules as well as the very late an- 
tigen (VLA) 4 (CD49d/CD29) member of the ~1 subfamily 
have been reported to contribute to eosinophil adherence to 
endothelium through binding to endothelial ligands, such 
as intraceUular and vascular cell adhesion molecule 1 (ICAM-1 
and VCAM-1) (8-12).  Blockage of integrins is believed  to 
hamper not only adherence to endothelium, but also the sub- 
sequent transendothelial  migration (diapedesis). Although the 
role of CD11/CD18 seems to be undisputed (12), the contri- 
bution of/~1 members (and VLA-4 in particular)  is less clear. 
From our present findings it is clear that several ~1 inte- 
grins contribute to eosinophil migration. Moreover, we dem- 
onstrate in the present study that a continuous modulation 
of integrins from low- to high-avidity state and vice versa 
is an essential requirement for cellular migratory responsive- 
ness. A disturbance in this avidity-switch mechanism results 
in  (an almost) complete inhibition of chemotaxis and di- 
apedesis. 
Materials  and Methods 
Eosinophil Purification.  Eosinophils were purified from healthy 
blood donors (13). After isolation, the eosinophils (>95%  pure) 
were washed and resuspended in incubation medium (132 mM 
NaC1,  1 mM MgSO4,  1  mM  CaC12, 6  mM  KC1, 1.2  mM 
KH2PO4, 20 mM Hepes, 10 U/ml heparin, 5.5 mM glucose, and 
0.5%  [wt/vol] human serum albumin, pH 7.4). 
Eosinophil Migration.  Chemotaxis was measured in a 48-well 
microchemotaxis chamber (NeuroProbe, Cabin John, MD) (14). 
Two cellulose  nitrate filters were placed  between the upper and lower 
compartments a lower stop filter (0.45-/~m pore size; Cat No. 
HAWP01300; Millipore  Corp., Bedford,  MA) and a migration filter 
(150-#m thick,  8-/~m pore size; Cat No.  11301.13.N; Sartorius 
GmbH, G6ttingen, Germany). Human umbilical vein endothelial 
cells (HUVEC) were subcultured  for 6 d on 10-20-~m thick nucleo- 
pore polycarbonate  membrane  filters  precoated  with fibronectin  (FN) 
(8-/~m pore size; Costar, Cambridge, MA) (15). These filters were 
placed on top of the migration filter, covering eight separate wells. 
The lack of  E-selectin together with low levels of  VCAM-1 expres- 
sion was considered evidence for the resting state of the HUVEC. 
Chemoattractant or incubation medium was placed in the lower 
compartments. Recombinant human C5a (rCSa) and PAF (Sigma 
Chemical Co., St. Louis, MO) were used as chemoattractants at 
concentrations defined  to be optimal in the assay: 10 -s and 1(3 -6 M, 
respectively. Eosinophils were preincubated with saturating con- 
centrations of mAb (15 min at 37°C) or incubation buffer, and 
subsequently added to the upper compartment (10  s cells in 25 #1). 
The chambers were incubated for 2.5 h at 37°C. The number of 
transmigrated cells reached a maximum at 2 h, most likely because 
the chemotactic gradient is reduced at that time. The migration 
filter was removed, fixed with butanol-ethanol,  and stained with 
Weigert's solution. Thee  number of  cells that had completely  passed 
the 150-#m-thick filter was determined with light microscopy in 
10 high power fields (at a magnification of 400) per filter. Sponta- 
neous migration without rCSa (chemokinesis)  consisted of one to 
three cells (mostly neutrophils)  in 10 high power fields  (at a magnifi- 
cation of 400) per filter. 
Eosinophil Adhesion.  Eosinophils  were labeled with SlChromi- 
um as described for neutrophils (15). After labeling, eosinophils 
were resuspended in incubation medium. Cells (10  s cells per well) 
were added to 48-well culture plates containing confluent HUVEC 
or fresh  coatings of  FN. After incubation  for 30 rain at 37°C, nonad- 
herent cells were removed, and their radioactivity was counted to- 
gether with two fixed volumes of washing buffer. Adherent cells 
were lysed with 1% Triton X-100 in water for 15 rain at 37°C. 
The radioactivity of these cells was also counted. 
Results and Discussion 
We  tested  the  migratory capacity  of eosinophils  in  a 
microchemotaxis chamber assay through 150-/~m thick filters 
toward the chemoattractants' recombinant complement frag- 
ment rC5a, or the lipid mediator PAF. When the migration 
filters were covered by confluent monolayers of HUVEC, di- 
apedesis was inhibited by the CD18 mAb CLB-LFA1/1 by 
60% and by the CD49d mAb HP1/2 by 30%, whereas eo- 
sinophil chemotaxis over untreated bare filters was inhibited 
only by the CD18 mAb (Fig.  1). 
Freezing of cells onto the substrates of adhesion molecules 
by inducing high-avidity binding was considered as an alter- 
native approach to interfere in eosinophil migration. The ac- 
tivating CD29 mAb 8A2 has recently been shown to increase 
adhesion of PBL and several hematopoietic clones and cell 
lines to the purified ECM proteins FN, or fragments thereof, 
and laminin (16, 17). Since bare polycarbonate filters lack ap- 
propriate ligands for VLA proteins, eosinophil chemotaxis 
across these bare uncoated filters was not affected by mAb 
8A2. By contrast, migration across filters covered by confluent 
HUVEC was inhibited to a significantly greater extent than 
observed  with either CD18  or CD49d mAb (Fig.  1). 
Although the procedure to stain the filters did not allow 
surface markers (e.g., CD16) to be used to distinguish between 
eosinophils and neutrophils, the morphology of the nucleus 
as well as the granular staining indicated that the cells that 
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Figure  1.  Eosinophil  migration  in response to recombinant  C5a is in- 
hibited by mAbs against the integrin receptor ~4, 81, and 82 subunits. 
The following  conditions  were  tested: (A) bare  untreated  falters;  (B) filters 
covered  by resting  endothelial  cells  derived  and subcultured  from  HUVEC; 
and (C) filters preincubated  with FN. Affanity-purified  CD49d (HP1/2, 
IgG1), CD29 (8A2, IgG1), and CD18 (CLB-LFA1/1,  IgG1) mAbs (10 
#g/ml final  concentration)  differentially  inhibited  eosinophil  migration. 
Migration in response to PAF gave identical results (data not shown). 
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neutrophils (about 5%).  Microscopic examination  revealed 
that the 8A2-treated eosinophils had not entered the migra- 
tion filter at all. After elimination of these neutrophils  by 
CD16-conjugated magnetic beads, the migration of the re- 
maining eosinophils across HUVEC-covered filters was com- 
pletely blocked by mAb 8A2 (data not shown). 
Because the endothelial cells had been subcultured on FN- 
precoated filters, we also measured eosinophil chemotaxis over 
filters preincubated with FN. Under these conditions, mAb 
8A2 markedly inhibited chemotaxis.  CD49d mAb reduced 
migration by about 60%, i.e., to a similar extent as had the 
CD18 mAb (Fig. 1). We performed similar experiments with 
neutrophils, but never observed any effect of mAb 8A2 under 
the various experimental conditions (i.e., bare, FN-preincu- 
bated or HUVEC-covered filters). On the other hand, neu- 
trophil migration was always fully inhibited by CD18 mAb 
(data not shown). 
Endothelial  cells are known to produce a complex ECM 
composed of several  proteins, such  as collagen, FN, and laminin 
(18-20). Many of these proteins are recognized by members 
of the  ~1  subfamily  previously  described  on  leukocytes: 
VLA- 1-6 (20-24). Surface expression of VLA-2o~, -4c~, -5o~, 
and -6or on eosinophils was demonstrated by flow cytometry 
(Table 1). To explain the complete inhibition of eosinophil 
migration through HUVEC-covered filters by the activating 
CD29 mAb 8A2, various blocking CD49 mAbs were tested. 
Although a role for VLA-6 seemed limited, VLA-2, -4, and 
-5 were definitely involved, as indicated by the significant in- 
hibition by the respective CD49 mAhs (Table 2). Eosinophil 
migration through FN-coated filters depended on VLA-4 and 
-5 (data not shown). 
To determine the mechanism by which VLA-4 functioned 
in the eosinophil diapedesis, further experiments  were per- 
formed to discriminate  between eosinophil binding to en- 
dothelial VCAM-1 vs the ECM protein FN. The major rec- 
ognition site for VLA-4  in FN has been localized to the 
connecting segment 1 (CS-1) region (25), comprising the 
Table  2.  Inhibition  of Eosinophil Diapedesis across HUVEC-covered 
Filters by raAbs against Various VLA-ot Subunits 
Number of cells 
Addition  Expt.  1  Expt. 2  Expt. 3  Inhibition 
% 
Control mAb  122  91  104  - 
CD49b  21  19  39  75  _+  7.4 
CD49d  64  57  70  40 _+  5.3 
CD49e  73  62  74  36  + 3.7 
CD49f  68  74  89  28  _+  9.6 
Number of cells represents the mean number of eosinophils migrated along 
a chemotactic gradient  of rCSa  through the 150-/zm filter,  counted in 
10 high power fields (400 x ) per filter.  Percent  inhibition is expressed 
as mean  _+  SEM. Migration was significantly inhibited by all CD49 mAbs 
listed (p <0.05).  CD49a as well as CD49c mAb did not show any inhi- 
bition (data  not shown). 
first 25 amino acids of the alternatively spliced III-CS  do- 
main (IIICS) (26). The activating CD29 mAb 8A2 enhances 
binding  of 31  integrin VLA-4  to  its  extracellular  ligand 
FN/CS-1, as well as to the cellular ligand VCAM-1 (16), and 
CD49d mAb HP1/2 inhibits both these VLA-4-mediated 
interactions  (27). Large numbers of eosinophils were found 
to bind to FN-coated plates in the presence of mAb 8A2 (Fig. 
2). mAb 8A2-stimulated  adhesion occurred in a rapid (op- 
timal within 15 min) and prolonged (more than 3 h) fashion. 
Binding of the mAb 8A2-activated eosinophils to FN was 
markedly inhibited by the CD49d mAh HP1/2 (Fig. 2). On 
the other hand, adherence of eosinophils to resting HUVEC 
was neither significantly induced by mAb 8A2, nor inhibited 
by mAb HP1/2. Thus, the mAb 8A2-dependent  inhibition 
of eosinophil migration through endothelium-covered filters 
Table  1.  Expression of VLA  Proteins on Eosinophils 
mAb  Specificity  Fluorescence 
Control mAb  anti-TNP  14.8  +  2.1 
CD49a TS2/7  VLA-lc~  14.9  _+  2.0 
CD49b Thromb/4  VLA-2ot  24.5  _+ 3.1 
CD49c J143  VLA-3oe  15.0  +  1.8 
CD49d HP1/2  VLA-4oe  55.8  +  4.9 
CD49e SAM-1  VLA-5o~  23.8  __ 4.7 
CD49f GoH3  VLA-6ct  30.0  _+  2.0 
Flow cytometric determination expressed  as mean  channel  of fluores- 
cence -+  SEM of four different experiments. Control antibody was directed 
against  TNP. 
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Figure 2.  CD29 mAb 8A2 stimulates eosinophil adherence to FN. The 
CD29 mAb 8A2 did not induce eosinophil adhesion to unstimulated  en- 
dothelium (EC), but VLA-4 and VLA-5-dependent adhesion to fibronectin 
(FN) was strongly induced. was not due to enhanced binding to the untreated endothelial 
monolayer.  The  anti-VCAM-1  mAb  4B9  (28)  did  not 
significantly inhibit eosinophil binding to or migration across 
resting HUVEC, which is in keeping with VCAM-1 expression 
being predominantly restricted to cytokine- (or endotoxin-) 
activated endothelium (29-32; data not shown). On the other 
hand, two out of three anti-CS-1 mAbs which will be more 
extensively described elsewhere (Gaeta, F. C. A., V. Tollefson, 
and M. J. Elices, manuscript in preparation), as well as soluble 
CS-1 peptide,  significantly reduced eosinophil diapedesis across 
HUVEC-covered filters  (Fig.  3) because of an inhibition of 
cell binding to FN (Fig. 4). All three anti-CS-1 mAbs recog- 
nized our plasma FN preparation from plasma as well as the 
ECM of subcultured HUVEC equally well, as determined 
by ELISA (data not shown).  Further control experiments 
showed that the addition of mAb HP1/2  to the blocking 
anti-CS-1 mAbs (90.45  and 116/32) or the CS-1 peptide did 
not result in any additional inhibition of eosinophil migra- 
tion and/or attachment. Moreover, neutrophil migration was 
not affected by either the anti-CS-1 mAbs or the soluble CS-1 
peptide (data not shown). In conclusion, mAb 8A2 most likely 
inhibited eosinophil diapedesis because of enhanced binding 
to the subendothelial matrix formed by HUVEC during cul- 
ture on the filters. 
To investigate the relative importance of/~2 vs/31  inte- 
grins, we further delineated the process of eosinophil migra- 
tion by using a blocking but nonactivating CD29 mAb AIIB2 
(33). mAb CD29 mAb AIIB2 (or the combination of CD49 
mAbs [CD49b, CD49d, CD49e, and CD49f]), failed to com- 
pletely inhibit eosinophil migration (Table 3). The same was 
true for CD18, as was shown before (Fig.  1). Only the com- 
bination of CD29 mAb AIIB2 with CD18 mAb prevented 
eosinophil migration as efficiently as the activating CD29 
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Figure 4.  Inhibition of 8A2-stimulated eosinophil adherence by anti- 
CS-1 mAbs or soluble CS-1 peptide. Experimental  approach was as de- 
scribed essentially in the legend of Fig. 3. The anti-CS-1 mAbs were prein- 
cubated with the HUVEC or FN coatings, whereas the eosinophils were 
preincubated with peptides before use. Binding to FN was significantly 
inhibited by mAb 90.45, mAb 116/32,  or the CS-I peptide (v <0.05). 
mAb 8A2 (Table 3). Microscopic examination revealed that 
the mechanism by which the activating CD29 mAb 8A2 in- 
hibited migration differed from the mechanism by which the 
blocking CD29 mAb AIIB2 and CD18 acted. Eosinophils 
preincubated with mAb 8A2 were completely prevented from 
entering the migration filter and adhered to the top filter cov- 
ered by HUVEC or preincubated with FN,  whereas with 
the combination of mAb AIIB2 and the CD18 mAb, very 
few cells were found on top of the filter indicating that eo- 
sinophil adherence was dramatically affected. 
90.45 
118/32 
A  118/45 
cs-  1  peptide 
C8-1  scrambled 
80.45 
116/32 
B  118148 
cs- 1  peptide 
CS- 1  sorambled 
90.45 
116/32 
C  118145 
cs-  1  peptide 
CS- 1  scrambled 
n.t. 
I 
t 
I 
i 
i 
i 
J  i 
60  80 
(%  of  control) 
J  i  i 
0  20  40  100  120 
Migration 
Figure 3.  Eosinophil migration in response to recombinant C5a is in- 
hibited by mAbs against CS-1 or the soluble CS-1 peptide. The same con- 
ditions as in Fig. I were tested. Filters were preincubated for 30 min with 
an optimal dilution (1:2-4) of hybridoma culture supernatant  in case of 
the anti-CS-1 mAbs 90.45 (IgM), 116/32 (IgM), and 118/45 (IgM) before 
the cells were added. In contrast,  eosinophils were preincubated with the 
CS-1 peptide (comprising the 25-amino acid sequence) or a scrambled ver- 
sion of the CS-1 amino acid sequence (up to 250 #g/ml) for 30 min at 
37°C before addition to the migration chambers. (B and C) Eosinophil 
migration was significantly inhibited by mAb 90.45, mAb 116/32, and 
the CS-1 peptide  (p <0.05).  (,4) mAb 116/32 was not tested (n.t.). 
Table  3.  Inhibition  of Eosinophil  Diapedesis  across 
HUVEC-covered Filters by mAbs against the fll (CD29) and f12 
(CD18) Subunits 
Addition 
Number of cells 
Expt.  1  Expt.  2  Expt.  3  Inhibition 
% 
Control mAb  97  116  112  - 
CD49  (combi)*  23  28  15  78  _+ 4.6 
CD29  (AllB2)  25  21  19  80  _+ 2.2 
CD18  30  52  44  61  _+  7.9 
CD18  and CD29 (AllB2)  3  2  4  97  _+ 0.8 
CD29  (8A2)  4  5  7  95  _+  1.2 
Number of cells represents the mean number of eosinophils migrated along 
a chemotactic  gradient of rCSa through the 150-/zm falter, counted in 
10 high power fields (400 x ) per filter. Percent inhibition is expressed 
as mean _+ SEM. Migration was significantly inhibited under the condi- 
tions tested  (p <0.05). 
* The  CD49  combination comprises  Thromb/4  (CD49b),  HP1/2 
(CD49d),  SAM-1 (CD49e),  and GoH3 (CD49f). 
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dearly defined by the CDll/CD18 molecules. However, the 
eosinophilic response became less dependent on CD18 as soon 
as substrates for VLA integrin receptors were made available 
(i.e.,  FN coated upon filters,  or ECM protein deposited by 
HUVEC  cultures)  (Fig.  1).  Concomitantly,  there was  a 
significant increase in inhibition of eosinophil migration by 
CD49d mAb HP1/2 from about 5% on bare, untreated filters, 
to 30% on filters with HUVEC, or 60% on FN-preincubated 
filters. The lesser inhibition of migration across HUVEC versus 
FN produced by the CD49d mAb (Fig.  1) is explained by 
the involvement of alternative VLA integrin receptors recog- 
nizing matrix proteins other than FN. HUVEC are able to 
generate a complex subendothelial matrix in which collagen 
and laminin are also important constituents (18-20). These 
proteins apparently function as the respective ECM ligands 
for VLA-2 and -6 expressed by eosinophils (Tables 1 and 2). 
For the first time, the VLA-4-CS-1 interaction is shown to 
be functionally involved in in vitro transendothelial migra- 
tion of a leukocyte population (Fig. 3). The relative distribu- 
tion and functional importance of FN splice variants in vivo 
are currently unknown. The control of mRNA splicing in 
the  IIICS  region  of FN  during  inflammation or  wound 
healing, for example, may thus contribute to the specificity 
of VLA-4 binding to its ligands (Elices, M. J., A. God, J. 
Fikes, and D. Strahl, manuscript submitted for publication). 
Even when the eosinophils were primed by cytokines (e.g., 
GM-CSF, IL-3, and IL-5) to enhance their chemotactic prop- 
erties (34),  as may occur with eosinophils from allergic pa- 
tients (12, 35), mAb 8A2 completely blocked migration of 
these primed eosinophils into HUVEC-covered or FN-coated 
filters  (data not shown). 
Activation of the ~1 integrin receptors by mAb 8A2 dra- 
matically interfered with eosinophil migration under condi- 
tions that mimic migration in vivo, i.e.,  chemotaxis across 
matrix-coated falters or diapedesis across HUVEC monolayers. 
These findings show that functional responses such as chemo- 
taxis or nondirected movement require that integrin receptors 
modulate binding avidity for ligand. Paralysis in low avidity 
state by low temperature or cellular ATP depletion (36,  and 
data not shown) will severely hamper binding. Conversely, 
an induced, persistent state of high-avidity binding will re- 
sult in loss of proper function as well. Freezing integrins in 
a high-avidity state may represent a novel approach to pre- 
vent a rapid tissue invasion by VLA-positive cells  during 
inflammation. Such an approach may not be limited to leu- 
kocytes. Since adhesion and invasion of tumor cells also in- 
volve ~1 integrins (29,  37),  activating ~1 mAbs might re- 
duce metastasis as well. 
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